Literature DB >> 17405908

Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis.

Cristina Cerboni1, Alessandra Zingoni, Marco Cippitelli, Mario Piccoli, Luigi Frati, Angela Santoni.   

Abstract

Recent evidence indicates that natural killer (NK) cells can negatively regulate T-cell responses, but the mechanisms behind this phenomenon as a consequence of NK-T-cell interactions are poorly understood. We studied the interaction between the NKG2D receptor and its ligands (NKG2DLs), and asked whether T cells expressed NKG2DLs in response to superantigen, alloantigen, or a specific antigenic peptide, and if this rendered them susceptible to NK lysis. As evaluated by FACS, the major histocompatibility complex (MHC) class I chain-related protein A (MICA) was the ligand expressed earlier on both CD4(+) and CD8(+) T cells in 90% of the donors tested, while UL16-binding protein-1 (ULBP)1, ULBP2, and ULBP3 were induced at later times in 55%-75% of the donors. By carboxyfluorescein diacetate succinimidyl ester (CFSE) labeling, we observed that NKG2DLs were expressed mainly on T cells that had gone through at least one division. Real-time reverse-transcription polymerase chain reaction confirmed the expression of all NKG2DLs, except ULBP4. In addition, T-cell activation stimulated phosphorylation of ataxia-telangiectasia mutated (ATM), a kinase required for NKG2DLs expression after DNA damage, and ATM/Rad3-related kinase (ATR) inhibitors blocked MICA induction on T cells with a mechanism involving NF-kappaB. Finally, we demonstrated that activated T cells became susceptible to autologous NK lysis via NKG2D/NKG2DLs interaction and granule exocytosis, suggesting that NK lysis of T lymphocytes via NKG2D may be an additional mechanism to limit T-cell responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17405908     DOI: 10.1182/blood-2006-10-052720

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  119 in total

Review 1.  Effect of NKG2D ligand expression on host immune responses.

Authors:  Marine Champsaur; Lewis L Lanier
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

2.  Yet another role for natural killer cells: cytotoxicity in immune regulation and viral persistence.

Authors:  Christine A Biron
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-31       Impact factor: 11.205

Review 3.  Natural killer cells and their receptors in multiple sclerosis.

Authors:  Gurman Kaur; John Trowsdale; Lars Fugger
Journal:  Brain       Date:  2012-06-25       Impact factor: 13.501

Review 4.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 5.  Immune surveillance of unhealthy cells by natural killer cells.

Authors:  Alexandre Iannello; David H Raulet
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2013-10-17

Review 6.  An integrated view of the regulation of NKG2D ligands.

Authors:  Noam Stern-Ginossar; Ofer Mandelboim
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

7.  Toxicity Induced by a Bispecific T Cell-Redirecting Protein Is Mediated by Both T Cells and Myeloid Cells in Immunocompetent Mice.

Authors:  Claire Godbersen-Palmer; Tiffany A Coupet; Zakaria Grada; Samuel C Zhang; Charles L Sentman
Journal:  J Immunol       Date:  2020-04-15       Impact factor: 5.422

Review 8.  Regulatory NK-cell functions in inflammation and autoimmunity.

Authors:  Anna Lünemann; Jan D Lünemann; Christian Münz
Journal:  Mol Med       Date:  2009-05-11       Impact factor: 6.354

9.  The depletion of NK cells prevents T cell exhaustion to efficiently control disseminating virus infection.

Authors:  Kevin D Cook; Jason K Whitmire
Journal:  J Immunol       Date:  2012-12-12       Impact factor: 5.422

10.  Antibody-Dependent Cellular Cytotoxicity against Reactivated HIV-1-Infected Cells.

Authors:  Wen Shi Lee; Jonathan Richard; Marit Lichtfuss; Amos B Smith; Jongwoo Park; Joel R Courter; Bruno N Melillo; Joseph G Sodroski; Daniel E Kaufmann; Andrés Finzi; Matthew S Parsons; Stephen J Kent
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.